Consistently, we have previously proposed that successful CFTR modulator drugs need to address not just the rescue of CFTR-mediated ion transport, but also CFTR protective role against EMT to protect individuals with CF from fibrosis and cancer propensity (14). This evidence concerns the gene CFTR and cystic fibrosis.